Aria Dibiase, MD
Advanced Heart Failure and Transplant Cardiology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 4 carriers
- Offices
- 8
- Since medical school
- 42 years
- Stanford University School of Medicine, 1984
Offices
8 locations · Sutter Bay Medical Foundation · Stanford Health Care
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
16 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dibiase’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G56433 · Current
Licensed to practise in California · since 1985 · expires 2027-10-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$190,890
Medicare paid this office $190,890 for 1,617 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 448 | $86,415 | $190 |
| Return visit (30+ min) | 184 | $39,207 | $113 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 156 | $34,144 | $216 |
| Long return visit (40+ min) | 58 | $11,895 | $153 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 632 | $6,327 | $7 |
See all 9 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 448 | $86,415 | $190 |
| Return visit (30+ min) | 184 | $39,207 | $113 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 156 | $34,144 | $216 |
| Long return visit (40+ min) | 58 | $11,895 | $153 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 632 | $6,327 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 231 | $2,978 | $13 |
| New patient visit (60+ min) | 11 | $2,304 | $209 |
| Ultrasound of heart, follow-up | 16 | $1,686 | $105 |
| Blood test, clotting time | 11 | $59 | $4 |
Who their Medicare patients are
1,617 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 19% · Women 51% · Also on Medicaid 18% · Health risk score 1.74. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 2.53.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Atrial fibrillation 40% · Chronic kidney disease 34% · Heart failure 33% · Diabetes 31% · Cancer 20% · Depression 19% · COPD 16% · Dementia 14% · Stroke 14%.
The office billed $890,595, Medicare allowed $261,568 and paid $190,890; for 2,318 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,617 | 2,318 | 76 | 1.74 | $890,595 | $190,890 |
| 2023 | 1,536 | 2,303 | 78 | 1.59 | $716,971 | $171,096 |
| 2022 | 1,374 | 2,228 | 78 | 1.32 | $709,786 | $175,385 |
| 2021 | 1,320 | 2,227 | 77 | 1.40 | $634,083 | $168,558 |
| 2020 | 999 | 1,675 | 78 | 1.35 | $510,159 | $132,435 |
| 2019 | 1,439 | 2,307 | 78 | 1.22 | $705,770 | $177,352 |
| 2018 | 1,551 | 2,164 | 76 | 1.21 | $714,942 | $178,246 |
| 2017 | 1,692 | 2,277 | 76 | 1.26 | $743,259 | $200,740 |
| 2016 | 1,592 | 2,282 | 77 | 1.33 | $680,575 | $180,818 |
| 2015 | 1,660 | 2,325 | 77 | 1.24 | $659,812 | $179,621 |
| 2014 | 1,552 | 2,255 | 76 | 1.18 | $714,333 | $198,704 |
| 2013 | 1,256 | 2,217 | 76 | 1.19 | $613,953 | $149,040 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 323 | $64,842 | $200 |
| Return visit (30+ min) | 202 | $44,834 | $112 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 115 | $26,537 | $231 |
| Long return visit (40+ min) | 57 | $12,548 | $165 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 692 | $6,151 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 192 | $2,571 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,459 | $73 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $788 | $24 |
| Heart muscle strain imaging | 16 | $639 | $40 |
| Blood test, clotting time | 43 | $281 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $260 | $24 |
| Anticoagulant management of patient taking warfarin | 16 | $157 | $8 |
2022: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 324 | $63,858 | $194 |
| Return visit (30+ min) | 195 | $40,959 | $113 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 138 | $32,080 | $231 |
| Long return visit (40+ min) | 64 | $14,241 | $166 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 289 | $3,842 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 380 | $3,749 | $7 |
| New patient visit (60+ min) | 13 | $2,709 | $208 |
| New patient visit (45+ min) | 11 | $1,768 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,441 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,361 | $124 |
| Anticoagulant management of patient taking warfarin | 48 | $706 | $9 |
| Blood test, clotting time | 76 | $692 | $4 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 40 | $664 | $16 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $635 | $35 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $422 | $26 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $271 | $14 |
| Injection, dobutamine hydrochloride, per 250 mg | 16 | $82 | None |
2021: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 269 | $55,590 | $206 |
| Return visit (30+ min) | 175 | $36,436 | $116 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 96 | $24,040 | $250 |
| Long return visit (40+ min) | 78 | $19,229 | $154 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 432 | $3,850 | $7 |
| New patient visit (60+ min) | 18 | $3,843 | $213 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 247 | $3,490 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 75 | $2,407 | $20 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,119 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,624 | $125 |
| New patient visit (45+ min) | 11 | $1,572 | $143 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $883 | $35 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 33 | $837 | $25 |
| Influenza vaccine split virus, preservative free | 12 | $783 | $65 |
| Heart muscle strain imaging | 16 | $738 | $43 |
| Blood test, clotting time | 82 | $695 | $4 |
| Heart rhythm recording of continous external ekg over 8-15 days | 28 | $459 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $362 | $28 |
| 3d radiographic procedure | 12 | $306 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $273 | $14 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $72 | None |
2020: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 224 | $46,505 | $206 |
| Return visit (30+ min) | 180 | $34,416 | $96 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 83 | $18,489 | $223 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 270 | $4,220 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,376 | $68 |
| Long return visit (40+ min) | 22 | $3,291 | $127 |
| New patient visit (45+ min) | 18 | $2,620 | $146 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,297 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,757 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 149 | $1,505 | $8 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,383 | $99 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $1,101 | $19 |
| Short return visit (20+ min) | 11 | $839 | $76 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 32 | $794 | $25 |
| Influenza vaccine split virus, preservative free | 11 | $671 | $61 |
| External ekg recording for more than 48 hours up to 21 days | 22 | $624 | $28 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $604 | $27 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $585 | $37 |
| Blood test, clotting time | 66 | $452 | $4 |
| Administration of influenza virus vaccine | 15 | $314 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $155 | $14 |
2019: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 300 | $60,486 | $201 |
| Return visit (30+ min) | 222 | $41,398 | $96 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 145 | $33,902 | $232 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 565 | $8,603 | $15 |
| Long return visit (40+ min) | 35 | $4,942 | $130 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,248 | $65 |
| New patient visit (45+ min) | 16 | $2,343 | $146 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 73 | $2,069 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 133 | $1,247 | $8 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,182 | $28 |
| Short return visit (20+ min) | 16 | $1,151 | $72 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $1,034 | $36 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $1,033 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $996 | $77 |
| Blood test, clotting time | 111 | $810 | $4 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $702 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $289 | $14 |
2018: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 313 | $64,419 | $203 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 167 | $37,773 | $226 |
| Return visit (30+ min) | 202 | $35,967 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 623 | $9,667 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,269 | $64 |
| Long return visit (40+ min) | 23 | $3,201 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,105 | $91 |
| New patient visit (45+ min) | 21 | $2,801 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,761 | $120 |
| Short return visit (20+ min) | 34 | $2,515 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 27 | $2,225 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 213 | $1,776 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 24 | $652 | $27 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $629 | $35 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $573 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $297 | $13 |
2017: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 372 | $82,177 | $220 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 160 | $41,770 | $258 |
| Return visit (30+ min) | 191 | $31,267 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 701 | $10,706 | $15 |
| Short return visit (20+ min) | 58 | $4,513 | $65 |
| Long return visit (40+ min) | 32 | $4,215 | $124 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $3,841 | $80 |
| New patient visit (45+ min) | 23 | $3,496 | $152 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,241 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,145 | $179 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,937 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 220 | $1,844 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,589 | $93 |
| Ultrasound of heart, follow-up | 11 | $1,381 | $126 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 21 | $965 | $33 |
| External ekg recording for more than 48 hours up to 21 days | 12 | $337 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $293 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $175 | $13 |
| Injection, dobutamine hydrochloride, per 250 mg | 12 | $53 | None |
2016: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 298 | $64,761 | $214 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 137 | $35,181 | $255 |
| Return visit (30+ min) | 164 | $28,359 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 620 | $9,470 | $15 |
| Short return visit (20+ min) | 65 | $5,453 | $62 |
| Long return visit (40+ min) | 33 | $5,120 | $131 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 47 | $3,969 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,447 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,118 | $89 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,907 | $116 |
| New patient visit (45+ min) | 20 | $2,780 | $139 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 300 | $2,407 | $6 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $767 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 11 | $747 | $68 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $697 | $54 |
| External ekg recording for more than 48 hours up to 21 days | 16 | $472 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 16 | $406 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $366 | $26 |
| Injection, dobutamine hydrochloride, per 250 mg | 15 | $64 | None |
2015: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 294 | $66,403 | $225 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 106 | $28,451 | $268 |
| Return visit (30+ min) | 159 | $28,039 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 756 | $11,864 | $15 |
| Short return visit (20+ min) | 85 | $8,455 | $64 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 60 | $5,288 | $85 |
| Long return visit (40+ min) | 27 | $3,825 | $137 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 14 | $3,466 | $248 |
| New patient visit (60+ min) | 15 | $2,872 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,786 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,635 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 197 | $1,829 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,789 | $128 |
| External ekg recording for more than 48 hours up to 21 days | 57 | $1,692 | $29 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 57 | $1,456 | $25 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 12 | $935 | $78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $767 | $37 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $383 | $14 |
2014: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 235 | $53,197 | $224 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 151 | $40,827 | $270 |
| Return visit (30+ min) | 153 | $27,864 | $91 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 86 | $20,976 | $238 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 699 | $10,696 | $15 |
| Short return visit (20+ min) | 95 | $9,704 | $66 |
| Long return visit (40+ min) | 48 | $6,292 | $123 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $5,314 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,697 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,338 | $63 |
| New patient visit (60+ min) | 12 | $2,146 | $179 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 20 | $1,248 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 98 | $1,083 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $862 | $54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $648 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 50 | $638 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $420 | $26 |
| Injection, dobutamine hydrochloride, per 250 mg | 16 | $73 | None |
2013: 15 services
| Return visit (30+ min) | 167 | $35,006 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 187 | $34,405 | $180 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 137 | $29,686 | $215 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 94 | $11,963 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 442 | $7,227 | $16 |
| Short return visit (20+ min) | 52 | $5,637 | $64 |
| Long return visit (40+ min) | 30 | $3,865 | $125 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 148 | $3,379 | $16 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 13 | $3,151 | $242 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,694 | $90 |
| Blood test, clotting time | 184 | $1,513 | $5 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $841 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $518 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $385 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $344 | $13 |
Medicaid work
$8,452 in 2024
Medicaid paid $8,452 for 739 billed services this clinician did in 2024, up to 107 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 739 | $8,452 |
| 2024 | 739 | 1 | 107 | $8,452 |
| 2023 | 373 | 1 | 65 | $2,812 |
| 2022 | 185 | 1 | 51 | $1,611 |
| 2021 | 216 | 1 | 45 | $2,061 |
| 2020 | 55 | 1 | 31 | $498 |
| 2019 | 16 | 1 | 16 | $122 |
| 2018 | 26 | 1 | 14 | $248 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 373 | $2,812 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 185 | $1,611 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 216 | $2,061 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 55 | $498 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 16 | $122 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $248 |
Drugs they prescribed that Part D paid
$1,657,911
Pharmacies billed $1,657,911 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,256) in 2024. At or below the middle of the specialty; the typical advanced heart failure and transplant cardiology clinician is at 0%.
1,872 generic and 384 brand-name prescriptions · $1,657,911 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vyndamax | 36 | $807,764 | $22,438 |
| Vyndaqel | 13 | $469,142 | $36,088 |
| Eliquis | 113 | $140,999 | $1,248 |
| Entresto | 125 | $119,391 | $955 |
| Farxiga | 32 | $34,351 | $1,073 |
See all 29 drugs
| Vyndamax | 36 | $807,764 | $22,438 |
| Vyndaqel | 13 | $469,142 | $36,088 |
| Eliquis | 113 | $140,999 | $1,248 |
| Entresto | 125 | $119,391 | $955 |
| Farxiga | 32 | $34,351 | $1,073 |
| Jardiance | 22 | $33,182 | $1,508 |
| Xarelto | 14 | $22,152 | $1,582 |
| Metoprolol | 322 | $4,713 | $15 |
| Atorvastatin | 275 | $2,736 | $10 |
| Rosuvastatin | 124 | $2,143 | $17 |
| Irbesartan | 129 | $1,951 | $15 |
| Carvedilol | 150 | $1,601 | $11 |
| Spironolactone-Hctz | 39 | $1,514 | $39 |
| Spironolactone | 89 | $1,103 | $12 |
| Valsartan | 38 | $1,089 | $29 |
| Bumetanide | 17 | $1,080 | $64 |
| Furosemide | 133 | $902 | $7 |
| Amlodipine Besylate | 131 | $874 | $7 |
| Eplerenone | 19 | $837 | $44 |
| Digoxin | 31 | $755 | $24 |
| Ramipril | 32 | $625 | $20 |
| Clopidogrel | 31 | $588 | $19 |
| Isosorbide Mononitrate Er | 30 | $445 | $15 |
| Potassium Chloride | 42 | $444 | $11 |
| Lisinopril | 51 | $412 | $8 |
| Losartan | 28 | $261 | $9 |
| Triamterene-Hydrochlorothiazid | 37 | $244 | $7 |
| Simvastatin | 21 | $154 | $7 |
| Hydrochlorothiazide | 19 | $54 | $3 |
Year by year
| 2024 | 2,256 | 246 | 0% (0) | 17% | $1,657,911 |
| 2023 | 2,290 | 238 | 0% (0) | 15% | $982,573 |
| 2022 | 2,398 | 248 | 0% (0) | 17% | $704,669 |
| 2021 | 2,477 | 250 | 0% (0) | 16% | $516,468 |
| 2020 | 2,399 | 234 | 0% (0) | 18% | $474,348 |
| 2019 | 2,222 | 251 | 0% (0) | 14% | $172,637 |
| 2018 | 2,401 | 239 | 0% (0) | 14% | $142,692 |
| 2017 | 2,082 | 226 | 0% (0) | 17% | $100,561 |
| 2016 | 2,143 | 216 | 0% (0) | 16% | $87,436 |
| 2015 | 2,176 | 210 | 0% (0) | None | $92,588 |
| 2014 | 2,281 | 199 | 0% (0) | 21% | $96,593 |
| 2013 | 2,377 | 180 | None | 22% | $101,167 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Vyndamax | 26 | $584,276 | $22,472 |
| Eliquis | 103 | $120,395 | $1,169 |
| Entresto | 115 | $118,025 | $1,026 |
| Jardiance | 29 | $39,901 | $1,376 |
| Xarelto | 16 | $25,705 | $1,607 |
| Farxiga | 18 | $24,218 | $1,345 |
| Metoprolol | 324 | $6,094 | $19 |
| Irbesartan | 138 | $4,448 | $32 |
| Atorvastatin | 294 | $4,192 | $14 |
| Valsartan | 63 | $2,583 | $41 |
| Rosuvastatin | 120 | $2,510 | $21 |
| Amiodarone | 20 | $2,064 | $103 |
| Carvedilol | 132 | $2,011 | $15 |
| Furosemide | 158 | $1,334 | $8 |
| Digoxin | 32 | $1,308 | $41 |
| Isosorbide Mononitrate Er | 40 | $1,162 | $29 |
| Clopidogrel | 54 | $1,145 | $21 |
| Spironolactone-Hctz | 24 | $1,088 | $45 |
| Bumetanide | 14 | $924 | $66 |
| Amlodipine Besylate | 123 | $897 | $7 |
| Losartan | 49 | $809 | $17 |
| Spironolactone | 68 | $772 | $11 |
| Lisinopril | 66 | $596 | $9 |
| Potassium Chloride | 33 | $584 | $18 |
| Ramipril | 46 | $451 | $10 |
| Triamterene-Hydrochlorothiazid | 43 | $431 | $10 |
| Simvastatin | 21 | $308 | $15 |
| Nitroglycerin | 11 | $160 | $15 |
2022: 28 drugs
| Vyndamax | 16 | $356,292 | $22,268 |
| Eliquis | 137 | $130,400 | $952 |
| Entresto | 107 | $94,213 | $880 |
| Xarelto | 22 | $33,019 | $1,501 |
| Jardiance | 20 | $26,769 | $1,338 |
| Farxiga | 12 | $18,113 | $1,509 |
| Metoprolol | 369 | $6,668 | $18 |
| Irbesartan | 147 | $4,764 | $32 |
| Atorvastatin | 264 | $3,502 | $13 |
| Carvedilol | 155 | $2,582 | $17 |
| Rosuvastatin | 88 | $2,442 | $28 |
| Valsartan | 60 | $1,947 | $32 |
| Furosemide | 166 | $1,438 | $9 |
| Spironolactone-Hctz | 24 | $1,438 | $60 |
| Isosorbide Mononitrate Er | 54 | $1,257 | $23 |
| Digoxin | 24 | $968 | $40 |
| Potassium Chloride | 55 | $953 | $17 |
| Lisinopril | 82 | $871 | $11 |
| Spironolactone | 69 | $862 | $12 |
| Ramipril | 53 | $829 | $16 |
| Amiodarone | 20 | $807 | $40 |
| Amlodipine Besylate | 115 | $779 | $7 |
| Clopidogrel | 43 | $775 | $18 |
| Bumetanide | 21 | $768 | $37 |
| Losartan | 47 | $735 | $16 |
| Triamterene-Hydrochlorothiazid | 42 | $427 | $10 |
| Warfarin | 14 | $261 | $19 |
| Simvastatin | 32 | $219 | $7 |
2021: 30 drugs
| Vyndamax | 12 | $255,183 | $21,265 |
| Eliquis | 119 | $99,424 | $835 |
| Entresto | 75 | $61,227 | $816 |
| Xarelto | 23 | $31,949 | $1,389 |
| Metoprolol | 397 | $7,839 | $20 |
| Irbesartan | 124 | $5,371 | $43 |
| Atorvastatin | 295 | $3,629 | $12 |
| Colchicine | 11 | $3,495 | $318 |
| Carvedilol | 182 | $2,574 | $14 |
| Valsartan | 53 | $2,190 | $41 |
| Rosuvastatin | 65 | $1,806 | $28 |
| Furosemide | 171 | $1,541 | $9 |
| Isosorbide Mononitrate Er | 71 | $1,427 | $20 |
| Digoxin | 23 | $1,368 | $59 |
| Potassium Chloride | 56 | $1,227 | $22 |
| Spironolactone-Hctz | 20 | $1,213 | $61 |
| Amlodipine Besylate | 157 | $910 | $6 |
| Bumetanide | 18 | $867 | $48 |
| Amiodarone | 19 | $864 | $45 |
| Ramipril | 68 | $828 | $12 |
| Olmesartan Medoxomil | 19 | $771 | $41 |
| Losartan | 47 | $747 | $16 |
| Lisinopril | 85 | $711 | $8 |
| Spironolactone | 69 | $663 | $10 |
| Clopidogrel | 39 | $522 | $13 |
| Verapamil Er | 15 | $460 | $31 |
| Triamterene-Hydrochlorothiazid | 36 | $391 | $11 |
| Fenofibrate | 11 | $295 | $27 |
| Warfarin | 18 | $271 | $15 |
| Simvastatin | 33 | $208 | $6 |
2020: 31 drugs
| Vyndamax | 11 | $233,918 | $21,265 |
| Eliquis | 98 | $81,528 | $832 |
| Entresto | 49 | $37,527 | $766 |
| Xarelto | 26 | $34,408 | $1,323 |
| Metoprolol | 371 | $9,549 | $26 |
| Colcrys | 13 | $5,780 | $445 |
| Irbesartan | 124 | $5,192 | $42 |
| Atorvastatin | 318 | $4,392 | $14 |
| Valsartan | 43 | $3,025 | $70 |
| Rosuvastatin | 52 | $2,783 | $54 |
| Carvedilol | 158 | $2,337 | $15 |
| Furosemide | 192 | $1,874 | $10 |
| Isosorbide Mononitrate Er | 71 | $1,579 | $22 |
| Spironolactone-Hctz | 27 | $1,449 | $54 |
| Lisinopril | 110 | $1,301 | $12 |
| Potassium Chloride | 49 | $1,282 | $26 |
| Ramipril | 67 | $1,213 | $18 |
| Bumetanide | 16 | $1,000 | $63 |
| Amlodipine Besylate | 124 | $923 | $7 |
| Losartan | 53 | $910 | $17 |
| Digoxin | 19 | $866 | $46 |
| Olmesartan Medoxomil | 18 | $660 | $37 |
| Klor-Con 10 | 16 | $568 | $36 |
| Clopidogrel | 38 | $563 | $15 |
| Verapamil Er | 13 | $500 | $38 |
| Spironolactone | 30 | $492 | $16 |
| Triamterene-Hydrochlorothiazid | 38 | $453 | $12 |
| Amiodarone | 27 | $453 | $17 |
| Warfarin | 25 | $451 | $18 |
| Simvastatin | 42 | $297 | $7 |
| Hydrochlorothiazide | 23 | $122 | $5 |
2019: 30 drugs
| Eliquis | 79 | $68,900 | $872 |
| Xarelto | 18 | $23,432 | $1,302 |
| Entresto | 18 | $15,309 | $850 |
| Metoprolol | 351 | $11,937 | $34 |
| Colcrys | 11 | $4,649 | $423 |
| Atorvastatin | 274 | $4,454 | $16 |
| Bumetanide | 30 | $2,994 | $100 |
| Irbesartan | 90 | $2,824 | $31 |
| Spironolactone-Hctz | 46 | $2,631 | $57 |
| Rosuvastatin | 51 | $2,552 | $50 |
| Potassium Chloride | 86 | $1,961 | $23 |
| Olmesartan Medoxomil | 21 | $1,766 | $84 |
| Carvedilol | 132 | $1,748 | $13 |
| Lisinopril | 117 | $1,576 | $13 |
| Furosemide | 154 | $1,418 | $9 |
| Isosorbide Mononitrate Er | 46 | $1,136 | $25 |
| Ramipril | 57 | $1,050 | $18 |
| Valsartan | 20 | $1,015 | $51 |
| Losartan | 49 | $661 | $13 |
| Verapamil Er | 14 | $628 | $45 |
| Amlodipine Besylate | 121 | $605 | $5 |
| Clopidogrel | 37 | $560 | $15 |
| Amiodarone | 34 | $537 | $16 |
| Simvastatin | 58 | $508 | $9 |
| Klor-Con 10 | 17 | $503 | $30 |
| Warfarin | 23 | $487 | $21 |
| Triamterene-Hydrochlorothiazid | 32 | $475 | $15 |
| Chlorthalidone | 13 | $371 | $29 |
| Spironolactone | 42 | $237 | $6 |
| Hydrochlorothiazide | 38 | $212 | $6 |
2018: 36 drugs
| Eliquis | 55 | $39,283 | $714 |
| Xarelto | 21 | $21,645 | $1,031 |
| Metoprolol | 382 | $13,061 | $34 |
| Entresto | 13 | $7,984 | $614 |
| Atorvastatin | 302 | $5,667 | $19 |
| Colcrys | 13 | $5,350 | $412 |
| Potassium Chloride | 114 | $5,064 | $44 |
| Coreg | 12 | $3,361 | $280 |
| Bumetanide | 25 | $3,278 | $131 |
| Rosuvastatin | 34 | $2,500 | $74 |
| Valsartan | 55 | $2,286 | $42 |
| Spironolactone-Hctz | 38 | $1,678 | $44 |
| Irbesartan | 75 | $1,589 | $21 |
| Furosemide | 208 | $1,416 | $7 |
| Digox | 14 | $1,391 | $99 |
| Lisinopril | 157 | $1,347 | $9 |
| Carvedilol | 132 | $1,133 | $9 |
| Olmesartan Medoxomil | 11 | $1,055 | $96 |
| Isosorbide Mononitrate Er | 40 | $995 | $25 |
| Warfarin | 31 | $963 | $31 |
| Ramipril | 57 | $912 | $16 |
| Losartan | 48 | $690 | $14 |
| Simvastatin | 85 | $643 | $8 |
| Verapamil Er | 11 | $609 | $55 |
| Amlodipine Besylate | 94 | $593 | $6 |
| Klor-Con 10 | 14 | $588 | $42 |
| Clopidogrel | 35 | $557 | $16 |
| Chlorthalidone | 19 | $504 | $27 |
| Triamterene-Hydrochlorothiazid | 43 | $480 | $11 |
| Amiodarone | 39 | $475 | $12 |
| Spironolactone | 32 | $452 | $14 |
| Levothyroxine | 18 | $326 | $18 |
| Benazepril | 14 | $280 | $20 |
| Jantoven | 13 | $215 | $17 |
| Atenolol | 11 | $143 | $13 |
| Hydrochlorothiazide | 34 | $124 | $4 |
2017: 33 drugs
| Eliquis | 25 | $20,156 | $806 |
| Metoprolol | 327 | $13,155 | $40 |
| Xarelto | 14 | $8,306 | $593 |
| Colcrys | 14 | $5,791 | $414 |
| Atorvastatin | 256 | $4,700 | $18 |
| Potassium Chloride | 84 | $3,271 | $39 |
| Coreg | 12 | $3,232 | $269 |
| Rosuvastatin | 20 | $1,926 | $96 |
| Digox | 16 | $1,408 | $88 |
| Furosemide | 206 | $1,304 | $6 |
| Spironolactone-Hctz | 28 | $1,200 | $43 |
| Carvedilol | 112 | $1,157 | $10 |
| Bumetanide | 19 | $1,129 | $59 |
| Valsartan | 25 | $1,086 | $43 |
| Warfarin | 35 | $983 | $28 |
| Lisinopril | 137 | $982 | $7 |
| Ramipril | 65 | $920 | $14 |
| Isosorbide Mononitrate Er | 33 | $804 | $24 |
| Irbesartan | 35 | $668 | $19 |
| Simvastatin | 74 | $642 | $9 |
| Amlodipine Besylate | 113 | $596 | $5 |
| Verapamil Er | 17 | $580 | $34 |
| Klor-Con Sprinkle | 16 | $578 | $36 |
| Losartan | 44 | $515 | $12 |
| Spironolactone | 26 | $429 | $17 |
| Triamterene-Hydrochlorothiazid | 31 | $410 | $13 |
| Benazepril | 17 | $339 | $20 |
| Torsemide | 11 | $316 | $29 |
| Clopidogrel | 21 | $313 | $15 |
| Levothyroxine | 18 | $304 | $17 |
| Amiodarone | 23 | $255 | $11 |
| Atenolol | 21 | $237 | $11 |
| Hydrochlorothiazide | 30 | $109 | $4 |
2016: 33 drugs
| Metoprolol | 299 | $10,831 | $36 |
| Benicar | 14 | $5,966 | $426 |
| Colcrys | 12 | $4,833 | $403 |
| Atorvastatin | 256 | $4,649 | $18 |
| Xarelto | 12 | $4,250 | $354 |
| Potassium Chloride | 90 | $3,428 | $38 |
| Coreg | 11 | $2,918 | $265 |
| Ramipril | 84 | $2,008 | $24 |
| Valsartan | 34 | $1,588 | $47 |
| Carvedilol | 126 | $1,531 | $12 |
| Furosemide | 202 | $1,524 | $8 |
| Lisinopril | 143 | $1,378 | $10 |
| Rosuvastatin | 11 | $1,226 | $111 |
| Digox | 19 | $1,191 | $63 |
| Warfarin | 50 | $1,101 | $22 |
| Bumetanide | 17 | $909 | $53 |
| Enalapril Maleate | 12 | $870 | $72 |
| Simvastatin | 94 | $817 | $9 |
| Isosorbide Mononitrate Er | 38 | $771 | $20 |
| Clopidogrel | 46 | $724 | $16 |
| Nitrostat | 16 | $649 | $41 |
| Spironolactone-Hctz | 16 | $622 | $39 |
| Spironolactone | 41 | $610 | $15 |
| Klor-Con M20 | 11 | $482 | $44 |
| Benazepril | 20 | $467 | $23 |
| Losartan | 46 | $428 | $9 |
| Verapamil Er | 18 | $414 | $23 |
| Amlodipine Besylate | 92 | $412 | $4 |
| Triamterene-Hydrochlorothiazid | 36 | $329 | $9 |
| Amiodarone | 26 | $273 | $10 |
| Atenolol | 19 | $233 | $12 |
| Hydrochlorothiazide | 48 | $183 | $4 |
| Metoprolol | 11 | $35 | $3 |
2015: 38 drugs
| Metoprolol | 262 | $11,555 | $44 |
| Crestor | 23 | $9,886 | $430 |
| Pradaxa | 16 | $7,579 | $474 |
| Potassium Chloride | 108 | $5,026 | $47 |
| Atorvastatin | 218 | $4,614 | $21 |
| Colcrys | 13 | $4,603 | $354 |
| Coreg | 11 | $2,774 | $252 |
| Valsartan | 20 | $2,504 | $125 |
| Benicar | 11 | $2,418 | $220 |
| Ramipril | 74 | $1,972 | $27 |
| Furosemide | 225 | $1,646 | $7 |
| Carvedilol | 143 | $1,523 | $11 |
| Lisinopril | 188 | $1,413 | $8 |
| Digox | 25 | $1,318 | $53 |
| Mexiletine | 14 | $1,213 | $87 |
| Warfarin | 44 | $1,138 | $26 |
| Isosorbide Mononitrate Er | 68 | $903 | $13 |
| Bumetanide | 13 | $861 | $66 |
| Klor-Con 10 | 14 | $858 | $61 |
| Digoxin | 18 | $832 | $46 |
| Enalapril Maleate | 17 | $725 | $43 |
| Amlodipine Besylate | 85 | $687 | $8 |
| Simvastatin | 81 | $667 | $8 |
| Spironolactone-Hctz | 12 | $495 | $41 |
| Amiodarone | 30 | $482 | $16 |
| Clopidogrel | 49 | $469 | $10 |
| Spironolactone | 36 | $463 | $13 |
| Pravastatin | 14 | $405 | $29 |
| Triamterene-Hydrochlorothiazid | 35 | $374 | $11 |
| Diltiazem 24hr Cd | 12 | $367 | $31 |
| Tamsulosin | 17 | $322 | $19 |
| Benazepril | 22 | $318 | $14 |
| Losartan | 25 | $231 | $9 |
| Verapamil Er | 16 | $160 | $10 |
| Hydrochlorothiazide | 29 | $139 | $5 |
| Atenolol | 14 | $131 | $9 |
| Propranolol | 12 | $54 | $4 |
| Metoprolol | 12 | $28 | $2 |
2014: 41 drugs
| Diovan | 57 | $19,479 | $342 |
| Metoprolol | 256 | $12,441 | $49 |
| Crestor | 18 | $5,824 | $324 |
| Benicar | 14 | $5,403 | $386 |
| Pradaxa | 14 | $5,224 | $373 |
| Colcrys | 14 | $4,458 | $318 |
| Potassium Chloride | 102 | $4,219 | $41 |
| Atorvastatin | 188 | $4,100 | $22 |
| Carvedilol | 190 | $2,713 | $14 |
| Valsartan | 17 | $2,696 | $159 |
| Digox | 30 | $1,964 | $65 |
| Coreg | 11 | $1,876 | $171 |
| Lisinopril | 156 | $1,497 | $10 |
| Ramipril | 54 | $1,418 | $26 |
| Furosemide | 233 | $1,329 | $6 |
| Isosorbide Mononitrate Er | 84 | $1,327 | $16 |
| Digoxin | 24 | $1,220 | $51 |
| Klor-Con 10 | 23 | $1,118 | $49 |
| Simvastatin | 91 | $1,028 | $11 |
| Diltiazem 24hr Cd | 13 | $1,000 | $77 |
| Warfarin | 69 | $968 | $14 |
| Benazepril | 38 | $925 | $24 |
| Pravastatin | 16 | $812 | $51 |
| Spironolactone | 67 | $749 | $11 |
| Mexiletine | 11 | $504 | $46 |
| Clopidogrel | 44 | $478 | $11 |
| Amlodipine Besylate | 60 | $476 | $8 |
| Amiodarone | 36 | $476 | $13 |
| Losartan | 35 | $441 | $13 |
| Spironolactone-Hctz | 15 | $420 | $28 |
| Triamterene-Hydrochlorothiazid | 34 | $416 | $12 |
| Enalapril Maleate | 19 | $405 | $21 |
| Hydralazine | 15 | $340 | $23 |
| Chlorthalidone | 14 | $309 | $22 |
| Bumetanide | 11 | $256 | $23 |
| Levothyroxine | 16 | $195 | $12 |
| Hydrochlorothiazide | 18 | $183 | $10 |
| Verapamil Er | 12 | $181 | $15 |
| Metoprolol | 18 | $122 | $7 |
| Atenolol | 16 | $121 | $8 |
| Propranolol | 12 | $48 | $4 |
2013: 39 drugs
| Diovan | 61 | $19,074 | $313 |
| Metoprolol | 263 | $14,499 | $55 |
| Crestor | 28 | $6,689 | $239 |
| Benicar | 28 | $6,223 | $222 |
| Carvedilol | 201 | $4,729 | $24 |
| Atorvastatin | 117 | $4,605 | $39 |
| Colcrys | 14 | $4,148 | $296 |
| Potassium Chloride | 93 | $3,460 | $37 |
| Isosorbide Mononitrate Er | 112 | $2,444 | $22 |
| Hydralazine | 53 | $1,933 | $36 |
| Micardis | 12 | $1,659 | $138 |
| Lisinopril | 150 | $1,599 | $11 |
| Clopidogrel | 54 | $1,550 | $29 |
| Ramipril | 68 | $1,511 | $22 |
| Mexiletine | 12 | $1,320 | $110 |
| Furosemide | 221 | $1,303 | $6 |
| Simvastatin | 94 | $1,192 | $13 |
| Pravastatin | 29 | $1,153 | $40 |
| Warfarin | 80 | $1,135 | $14 |
| Spironolactone | 57 | $911 | $16 |
| Klor-Con 10 | 23 | $908 | $39 |
| Benazepril | 35 | $904 | $26 |
| Amiodarone | 33 | $610 | $18 |
| Amlodipine Besylate | 60 | $520 | $9 |
| Diltiazem 24hr Cd | 21 | $504 | $24 |
| Triamterene-Hctz | 55 | $503 | $9 |
| Felodipine Er | 13 | $452 | $35 |
| Enalapril Maleate | 23 | $412 | $18 |
| Losartan | 20 | $407 | $20 |
| Digox | 28 | $354 | $13 |
| Digoxin | 25 | $338 | $14 |
| Spironolactone-Hctz | 17 | $271 | $16 |
| Verapamil Er | 12 | $268 | $22 |
| Hydrochlorothiazide | 49 | $253 | $5 |
| Bumetanide | 11 | $191 | $17 |
| Nitrostat | 12 | $147 | $12 |
| Atenolol | 23 | $139 | $6 |
| Metoprolol | 17 | $98 | $6 |
| Propranolol | 12 | $48 | $4 |
Money from drug and device companies
$129 in 2024
| 2024 | 1 | 1 | None | $129 |
| 2023 | 1 | 1 | None | $202 |
| 2020 | 1 | 1 | None | $142 |
| 2019 | 2 | 3 | $3,000 | $3,213 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Impulse Dynamics (USA) | Optimizer | $129 | 1 payment
|
See the published payment
| Impulse Dynamics (USA) | Meals · 2024-07-10 | Optimizer | $129 |
See earlier years (2023, 2020, 2019)
2023: $202
| Edwards Lifesciences | None | $202 | 1 payment
|
2020: $142
| Abbott Laboratories | Mitra Clip System | $142 | 1 payment
|
2019: $3,213
| Biotronik | None | $3,199 | 2 payments
|
| Amgen | Repatha | $13 | 1 payment
|
Professional record
- NPI
- 1033273727
- Licence
- CA G56433California G56433: Current · expires 2027-10-31
- Trained
- Stanford University School of Medicine, 1984 · 42 years ago
- Group
- Sutter Bay Medical Foundation · Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0001X (207RA0001X); Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-12-20
- NPI last updated
- 2020-02-18
- NPI record certified
- 2020-02-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301